[Peculiarities of creating permanent vascular access in diabetic patients on programmed haemodialysis].

Over the period from 2004 to 2009, we performed a total of 18 procedures aimed at forming a permanent vascular access in diabetic patients on programmed haemodialysis. Of these, an arteriovenous fistula (AVF) was created in eight patients and a polytetrafluoroethylene (PTFE) graft was implanted in ten subjects. We than carried out a comparative assessment of the permanent vascular accesses (PVA) prepared based on AVF versus those based on PTFE graft. The assessment criteria were as follows: time interval between the operative intervention and the commencement of the haemodialysis procedure via the PVA, the duration of the functioning and adequate amount of blood flow the PVA provides during the haemodialysis procedure, the presence of antebrachial ischaemia symptoms, as well as infectious complication rates.

[Initial experience with the surgical treatment of hypertrophic cardiopathy using an apico-aortic valved conduit]. / Pervyi opyt khirurgicheskogo lecheniia gipertroficheskoi kardiopatii s ispol'zovaniem klapansoderzhashchego apiko-aortal'nogo konduita.

Long-term results (up to 3 years) of operative treatment of first patients with complex obstruction of the left ventricle outflow tract (hypertrophic cardiomyopathy--10 patients, congenital subaortic tunnel stenosis--1 patient) with the help of apico-aortic valved conduit are presented. There was no intrahospital lethality. Two patients died in late terms after operation who had been operated upon for the III degree of circulation insufficiency. Complications associated with using the valved conduit were not noted. All the patients operated upon did not need medicamentous therapy (indirect anticoagulants excluded), seven of them had the 1st functional class NYHA by the moment of examination, two had the 2nd functional class. Continuous observations have revealed a marked tendency to normalization of the hemo- and cardiodynamic parameters.